Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine

References

• BOURRIE, M., MEUNIER, A., BERGER, Y. and FABRE, G., 1996, Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. Journal of Pharmacology and Experimental Therapeutics, 277, 321–332.
   PubMed Web of Science ®Google Scholar
• CHING, M. S., BICHARA, N., BLAKE, C. L., GHABRIAL, H., TUKEY, R. H. and SMALLWOOD, R. A., 1996, Propranolol 4- and 5-hydroxylation and N-desisopropylation by cloned human cytochrome P4501A1 and 1A2. Drug Metabolism and Disposition, 24, 692–694.
   PubMed Web of Science ®Google Scholar
• CHING, M. S., BLAKE, C. L., GHABRIAL, H., ELLIS, S. W., LENNARD, M. S., TUCKER, G. T. and SMALLWOOD, R. A., 1995, Potent inhibition of yeast expressed CYP2D6 by dihydroquinidine, quinidine, and its metabolites. Biochemical Pharmacology, 50, 833–837.
   PubMed Web of Science ®Google Scholar
• CHING, M. S., LENNARD, M. S., TUCKER, G. T., WOODS, H. F., KELLY, D. E. and KELLY, S. L., 1991, The expression of human cytochrome P4501A1 in the yeast Saccharomyces cerevisiae. Biochemical Pharmacology, 42, 753–758.
   PubMed Web of Science ®Google Scholar
• CLARKE, S. E., AYRTON, A. D. and CHENERY, R. J., 1994, Characterization of the inhibition of P4501A2 by furafylline. Xenobiotica, 24, 517–526.
   PubMed Web of Science ®Google Scholar
• GUENGERICH, F. P, MOLLER-ENOCH, D. and BLAIR, I. A., 1986, Oxidation of quinidine by human liver cytochrome P-450. Molecular Pharmacology, 30, 287–295.
   Google Scholar
• GUENTERT, T. W., DALY, J. J. and RIEGELMAN, S., 1982, Isolation, characterisation and synthesis of a new quinidine metabolite. European Journal of Drug Metabdismand Pharmacokinetics, 7, 31–38.
   PubMedGoogle Scholar
• IOANNIDES, C. and PARKE, D. V., 1987, The cytochromes P-448—a unique family of enzymes involved in chemical toxicity and carcinogenesis. Biochemical Pharmacology, 36, 4197–4207.
   PubMed Web of Science ®Google Scholar
• JOHNSON, J. A., HERRING, V. L., WOLFE, M. S. and RELLING, M. V., 2000, CYP1A2 and CYP2D6 4-hydroxylate propranolol and both reactions exhibit racial differences. Journal of Pharmacology and Experimental Therapeutics, 294, 1099–1105.
   PubMed Web of Science ®Google Scholar
• Kunze, K. L. and TRAGER, W. F., 1993 Isoform-selective mechanism based inhibition of human cytochrome P450 by furafylline. Chemical Research in Toxicology, 6, 649–656.
   PubMed Web of Science ®Google Scholar
• LEWIS, D. F. V., 2000, On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics. Biochemical Pharmacology, 60, 293–306.
   PubMed Web of Science ®Google Scholar
• Lewis, D. F. V. and LAKE, B. G., 1996, Molecular modelling of CYP1A subfamily memebers based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica, 26, 723–753.
   Google Scholar
• LOZANO, J. J., LOPEZ-DE-BaiS)As, E., CENTENO, N. B., GuiGO, R. and SANZ, F., 1997, Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and Mel Q. Journal of Computer Aided Molecular Design, 11, 395–408.
   Google Scholar
• MURRAY, B. P., EDWARDS, R. J., MURRAY, S., SINGLETON, A. M., DAVIES, D. S. and BOOBIS A. R., 1993, Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis, 14, 585–592.
   Google Scholar
• Newton, D. J., Wang, R. W. and Lu, A. Y. H., 1985, Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metabolism and Disposition, 23, 154–158.
   Google Scholar
• ONO, S., HATANAKA, T., HOTTA, H., SATOH, T., GONZALEZ, F.J. and TSUTSUI, M., 1996, Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica, 26, 681–693.
   PubMed Web of Science ®Google Scholar
• OrroN, S. V., BRINN, R. U. and GRAM, L. F., 1988, In vitro evidence against the oxidation of quinidine by the sparteine/debrisoquine monooygenase of human liver. Drug Metabolism Disposition, 16, 15–17.
   PubMedGoogle Scholar
• PASTRAKULHC, A., TANG, B. K., ROBERTS, E. A. and KALow, W., 1997, Distinction of CYP1A1 and CYP1 A2 activity by selective inhibition using fluvoxamine and isosafrole. Biochemical Pharmacology, 53, 531–538.
   PubMedGoogle Scholar
• PENMAN, B. W., LIPING, C., GELBOIN, H. V., GONZALEZ, F. J. and CRESPI, C. L., 1994, Deveopment of a human lymphoblastoid cell line constitutively expressing human liver CYP1A1 cDNA: substrate specificity with model substrates and promutagens. Carcinogenesis, 15, 1931–1937.
   PubMed Web of Science ®Google Scholar
• RAKHIT, A. and Mico, B., 1985, Kinetics of microsomal metabolism of quinidine in rats. Research and Communications and Chemical Pathology and Pharmacology, 49, 109–124.
   Google Scholar
• SA1, Y., DAI, R., YANG, T. J., KRAUSZ, K. W., GONZALEZ, F. J., GELBOIN, H. V. and Snou, M., 2000, Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochrome P450. Xenobiotica, 30, 327–343.
   Google Scholar
• SEGEL, H., 1975, Enzyme Kinetics—Behaviour and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems (New York: Wiley), pp. 18–99.
   Google Scholar
• SOLOMON, B. P., 1987, Determination of acetaminophen in plasma. Current Separations, 8, 58–59.
   Google Scholar
• TASSANEEYAKUL, W., BIRKETT, D. J., VERONESE, M. E., McMANus, M. E., TUKEY, R. H. and MINERS, J. 0., 1994, Direct characterization of the selectivity of furafylline as an inhibitor of human cytochromes P450 1A1 and 1A2. Pharmacogenetics, 4, 281–284.
   Google Scholar
• ZHAO, XJ., YOKOYAMA, H., CHIBA, K., WANWIMOLRUK, S. and ISHIZAKI, T., 1996, Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human liver microsomes and nine recombinant human cytochromes P450. Journal of Pharmacology and Experimental Therapeutics, 279, 1327–1334.
   PubMedGoogle Scholar
• ZVELEBIL, M. J. J., WOLF, C. R. and STERNBERG, M. J. E., 1991, A predicted three-dimensional structure of human cytochrome P450: implications for substrate specificity. Protein Engineer, 4, 271–282.
   Google Scholar